EUVIMEDOpdag EUVIMED
Multizentrische StudieBeobachtungsstudieOpen access · CC BY 4.0

Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS

Martin Andreas Kabelitz, Simon Johannes Gairing, Anja Tiede iD, Eva Maria Schleicher, Liv Grete Ahl, Lea Wagner, Falko Zucker-Reimann, Hannah Rieland, Jim Benjamin Mauz, Julia Weinmann-Menke, Bernhard C Meyer, Michael Bernhard Pitton and 5 more

Alimentary Pharmacology & Therapeutics · 2026

DOI: 10.1111/apt.70315 ↗

At a glance

Multizentrische Studie in Alimentary Pharmacology & Therapeutics, 2026. Written by Martin Andreas Kabelitz and 16 co-authors. Institution: Department for Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany. Major MEDLINE topics: Frailty, Liver Cirrhosis, Portasystemic Shunt, Transjugular Intrahepatic. Cited 6 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsches Zentrum für Infektionsforschung, Dr. Rolf M. Schwiete Stiftung.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Aims Frailty is associated with a poorer prognosis of patients awaiting liver transplantation. Data on the impact of frailty on prognosis after transjugular intrahepatic portosystemic shunt (TIPS)‐insertion in patients with cirrhosis and the influence of TIPS on longitudinal changes in frailty are lacking.

Methods

We retrospectively analysed data of 123 prospectively recruited patients with cirrhosis in Mainz and Hannover prior to elective TIPS insertion and monitored them for death/liver transplantation or post‐TIPS overt hepatic encephalopathy (OHE). Patients underwent testing with the Liver Frailty Index (LFI) prior to TIPS insertion as well as 1, 3 and 6 months after TIPS placement.

Results

Median LFI prior to TIPS insertion was 4.32 (interquartile range: 3.78–4.88). 53% of patients who were frail at baseline and still alive at 6 months improved to prefrail status within 6 months of TIPS insertion. Higher LFI and younger age were associated with a decrease in LFI within 6 months. During follow‐up, 40 patients developed post‐TIPS OHE and 30 patients died or received a liver transplantation. There was no significant association between LFI as a metric variable and post‐TIPS OHE or liver transplantation/death. However, patients with LFI values in the lowest quartile had a significantly better transplantation‐free survival.

Conclusions

TIPS insertion seems to improve physical functioning, as indicated by a decreasing LFI, but only in patients with a poor performance in LFI prior to TIPS. Conducting LFI prior to elective TIPS insertion can identify those with an excellent prognosis. However, frailty should not be considered a contraindication for TIPS. Trial Registration ClinicalTrials.gov identifier: NCT05466669 and NCT04801290

Subjects

MeSH terms (MEDLINE)

FrailtyLiver CirrhosisPortasystemic Shunt, Transjugular IntrahepaticAgedFemaleHumansMaleMiddle AgedHepatic EncephalopathyLiver TransplantationPrognosisRetrospective Studies

Author keywords

TIPSfrailtyhepatic encephalopathyliver cirrhosistransjugular intrahepatic portosystemic shunt

Authors and institutions

  • Department for Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
  • Cirrhosis Center Mainz (CCM), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
  • German Center for Infectious Research, Partner Site Hannover-Braunschweig, Braunschweig, Germany.
  • Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.

ORCID profiles: Anja Tiede, Heiner Wedemeyer, Lisa Sandmann, Benjamin Maasoumy, Christian Labenz

Funding

  • Deutsches Zentrum für Infektionsforschung
  • Dr. Rolf M. Schwiete Stiftung

Cite

APA

Kabelitz, M. A., Gairing, S. J., Tiede, A., Schleicher, E. M., Ahl, L. G., Wagner, L., Zucker-Reimann, F., Rieland, H., Mauz, J. B., Weinmann-Menke, J., Meyer, B. C., Pitton, M. B., Wedemeyer, H., Galle, P. R., Sandmann, L., Maasoumy, B., & Labenz, C. (2026). Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70315

Vancouver

Kabelitz MA, Gairing SJ, Tiede A, Schleicher EM, Ahl LG, Wagner L, et al. Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70315

BibTeX
@article{Kabelitz2026,
  author = {Kabelitz, Martin Andreas and Gairing, Simon Johannes and Tiede, Anja and Schleicher, Eva Maria and Ahl, Liv Grete and Wagner, Lea and Zucker-Reimann, Falko and Rieland, Hannah and Mauz, Jim Benjamin and Weinmann-Menke, Julia and Meyer, Bernhard C and Pitton, Michael Bernhard and Wedemeyer, Heiner and Galle, Peter Robert and Sandmann, Lisa and Maasoumy, Benjamin and Labenz, Christian},
  title = {Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70315}
}
Start for free →